On Air Now

Listen

Listen Live Now » 101.9 FM Central Wisconsin

Weather

Current Conditions(Wausau,WI 54403)

More Weather »
64° Feels Like: 64°
Wind: W 6 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Today

Mostly Sunny 74°

Tonight

Thunderstorms Early 55°

Tomorrow

Partly Cloudy 79°

Alerts

Spectrum Pharma's blood cancer drug meets goal in mid-stage trial

(Reuters) - Spectrum Pharmaceuticals Inc said a mid-stage trial of its experimental blood cancer drug met the main goal of shrinking tumors.

The drug, belinostat, was tested in patients with relapsed/refractory peripheral T-Cell (PTCL) lymphoma, who have failed at least one therapy.

The biotechnology company said it expects to file a marketing application with U.S. health regulators by mid-2013, and expects a review date in 2014.

Belinostat was granted orphan-drug status and fast-track status by the U.S. Food and Drug Administration for PTCL.

Spectrum's shares, which have fallen about 22 percent in the last year, closed at $11.30 on the Nasdaq on Thursday.

(Reporting By Vrinda Manocha in Bangalore; Editing by Don Sebastian)

Comments